SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-199234
Filing Date
2014-05-14
Accepted
2014-05-14 17:01:06
Documents
14
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d707597d10q.htm 10-Q 921594
2 EX-10.6 d707597dex106.htm EX-10.6 133573
3 EX-31.1 d707597dex311.htm EX-31.1 7961
4 EX-31.2 d707597dex312.htm EX-31.2 8013
5 EX-32.1 d707597dex321.htm EX-32.1 3958
6 EX-32.2 d707597dex322.htm EX-32.2 4010
7 EX-99.1 d707597dex991.htm EX-99.1 7580
14 GRAPHIC g707597v1.jpg GRAPHIC 8221
  Complete submission text file 0001193125-14-199234.txt   6652606

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rvnc-20140331.xml EX-101.INS 730842
9 XBRL TAXONOMY EXTENSION SCHEMA rvnc-20140331.xsd EX-101.SCH 66364
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvnc-20140331_cal.xml EX-101.CAL 58805
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvnc-20140331_def.xml EX-101.DEF 275621
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvnc-20140331_lab.xml EX-101.LAB 515797
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvnc-20140331_pre.xml EX-101.PRE 375506
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 14842298
SIC: 2834 Pharmaceutical Preparations